For patients, visible symptoms of uveitis correlate with perceptions of worse physical health, according to a recent study. Ophthalmologist Sunil Srivastava, MD, and rheumatologists Rula Hajj-Ali, Joshua Hedrick, MD, explain the relationship between patient reported outcomes measures and disease activity in inflammatory eye disease.
Novel Image Analysis Platform May Detect Early Signs of Retinal Toxicity Secondary to Hydroxychloroquine Use
Ellipsoid zone mapping, a new image visualization/analysis platform on optical coherence tomography, may be an effective screening tool to identify subtle retinal changes indicative of toxicity from hydroxychloroquine treatment, Cleveland Clinic research indicates.
OCTA Proves Valuable in Detecting Choroidal Neovascularization in Uveitis
In high-risk uveitis patients, OCTA can help identify complications early on so that treatment can be initiated, potentially preventing vision loss. OCTA is on its way to standard use in uveitis subspecialty practices.
Race Against Vision Loss in Inflammatory Eye Disease
Uveitis accounts for 10-15 percent of legal blindness in the United States. At Cleveland Clinic, multicenter collaboration, fast-track evaluation and treatment help patients avoid vision loss.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy